RT Journal Article
SR Electronic
T1 Risk Factors, Clinical Outcomes and Prognostic Factors of Bacterial Keratitis: The Nottingham Infectious Keratitis Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.05.26.21257881
DO 10.1101/2021.05.26.21257881
A1 Darren S. J. Ting
A1 Jessica Cairns
A1 Bhavesh P. Gopal
A1 Charlotte Shan Ho
A1 Lazar Krstic
A1 Ahmad Elsahn
A1 Michelle Lister
A1 Dalia G. Said
A1 Harminder S. Dua
YR 2021
UL http://medrxiv.org/content/early/2021/06/05/2021.05.26.21257881.abstract
AB Background/aim To examine the risk factors, clinical characteristics, outcomes and prognostic factors of bacterial keratitis (BK) in Nottingham, UK.Methods This was a retrospective study of patients who presented to the Queen’s Medical Centre, Nottingham, with suspected BK during 2015-2019. Relevant data, including the demographic factors, risk factors, clinical outcomes, and potential prognostic factors, were analysed.Results A total of 283 patients (n=283 eyes) were included; mean age was 54.4±21.0 years and 50.9% were male. Of 283 cases, 128 (45.2%) cases were culture-positive. Relevant risk factors were identified in 96.5% patients, with ocular surface diseases (47.3%), contact lens wear (35.3%) and systemic immunosuppression (18.4%) being the most common factors. Contact lens wear was most commonly associated with P. aeruginosa whereas Staphylococci spp. were most commonly implicated in non-contact lens-related BK cases (p=0.017). At presentation, culture-positive cases were associated with older age, worse presenting corrected-distance-visual-acuity (CDVA), larger epithelial defect and infiltrate, central location and hypopyon (all p<0.01), when compared to culture-negative cases. Hospitalisation was required in 57.2% patients, with a mean length of stay of 8.0±8.3 days. Surgical intervention was required in 16.3% patients. Significant complications such as threatened/actual corneal perforation (8.8%), loss of perception of light vision (3.9%), and evisceration/enucleation (1.4%) were noted. Poor visual outcome (final corrected-distance-visual-acuity of <0.6 logMAR) and delayed corneal healing (>30 days from initial presentation) were significantly affected by age >50 years, infiltrate size >3mm, and reduced presenting vision (all p<0.05).Conclusion BK represents a significant ocular morbidity in the UK. Culture positivity is associated with more severe disease at presentation but has no significant influence on the final outcome. Older age, large infiltrate, and poor presenting vision were predictive of poor visual outcome and delayed corneal healing, highlighting the importance of primary prevention and early intervention for BK.Competing Interest StatementThe authors have declared no competing interest.Funding StatementD.S.J.T. acknowledges support from the Medical Research Council / Fight for Sight Clinical Research Fellowship (MR/T001674/1) and the Fight for Sight / John Lee, Royal College of Ophthalmologists Primer Fellowship (24CO4).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved by the Clinical Governance team in the Nottingham University Hospitals NHS Trust as a clinical audit (Ref: 19-265C).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are provided in the paper.